Anti-GFRA4 monoclonal antibody

Anti-GFRA4 antibody for FACS & in-vivo assay

Target products collectionGo to GFRA4/GFRA4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0480-Ab-1/ GM-Tg-hg-MP0480-Ab-2Anti-Human GFRA4 monoclonal antibodyHuman
GM-Tg-rg-MP0480-Ab-1/ GM-Tg-rg-MP0480-Ab-2Anti-Rat GFRA4 monoclonal antibodyRat
GM-Tg-mg-MP0480-Ab-1/ GM-Tg-mg-MP0480-Ab-2Anti-Mouse GFRA4 monoclonal antibodyMouse
GM-Tg-cynog-MP0480-Ab-1/ GM-Tg-cynog-MP0480-Ab-2Anti-Cynomolgus/ Rhesus macaque GFRA4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0480-Ab-1/ GM-Tg-felg-MP0480-Ab-2Anti-Feline GFRA4 monoclonal antibodyFeline
GM-Tg-cang-MP0480-Ab-1/ GM-Tg-cang-MP0480-Ab-2Anti-Canine GFRA4 monoclonal antibodyCanine
GM-Tg-bovg-MP0480-Ab-1/ GM-Tg-bovg-MP0480-Ab-2Anti-Bovine GFRA4 monoclonal antibodyBovine
GM-Tg-equg-MP0480-Ab-1/ GM-Tg-equg-MP0480-Ab-2Anti-Equine GFRA4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0480-Ab-1/ GM-Tg-hg-MP0480-Ab-2; GM-Tg-rg-MP0480-Ab-1/ GM-Tg-rg-MP0480-Ab-2;
GM-Tg-mg-MP0480-Ab-1/ GM-Tg-mg-MP0480-Ab-2; GM-Tg-cynog-MP0480-Ab-1/ GM-Tg-cynog-MP0480-Ab-2;
GM-Tg-felg-MP0480-Ab-1/ GM-Tg-felg-MP0480-Ab-2; GM-Tg-cang-MP0480-Ab-1/ GM-Tg-cang-MP0480-Ab-2;
GM-Tg-bovg-MP0480-Ab-1/ GM-Tg-bovg-MP0480-Ab-2; GM-Tg-equg-MP0480-Ab-1/ GM-Tg-equg-MP0480-Ab-2
Products NameAnti-GFRA4 monoclonal antibody
Formatmab
Target NameGFRA4
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GFRA4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GFRA4 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-MP0480-Ag-1GDNF family receptor alpha 4 (GFRA4) protein


    Target information

    Target IDGM-MP0480
    Target NameGFRA4
    Gene ID64096,14588,66023,718481,609182,101093766,618480,100066406
    Gene Symbol and SynonymsG630015H18Rik,GFRA4
    Uniprot AccessionQ9GZZ7,Q9EPI2
    Uniprot Entry NameGFRA4_HUMAN,GFRA4_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000125861
    Target ClassificationN/A

    The target: GFRA4, gene name: GFRA4, also named as . The protein encoded by this gene is a member of the GDNF receptor family. It is a glycosylphosphatidylinositol(GPI)-linked cell surface receptor for persephin, and mediates activation of the RET tyrosine kinase receptor. This gene is a candidate gene for RET-associated diseases. Alternatively spliced transcript variants encoding different isoforms have been described for this gene..



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.